2020
Genetic Variation and Response to Neurocritical Illness: a Powerful Approach to Identify Novel Pathophysiological Mechanisms and Therapeutic Targets
Acosta JN, Brown SC, Falcone GJ. Genetic Variation and Response to Neurocritical Illness: a Powerful Approach to Identify Novel Pathophysiological Mechanisms and Therapeutic Targets. Neurotherapeutics 2020, 17: 581-592. PMID: 31975153, PMCID: PMC7283396, DOI: 10.1007/s13311-020-00837-2.Peer-Reviewed Original ResearchConceptsIll neurological patientsNovel pathophysiological mechanismsFinal FDA approvalNeurocritical illnessPathophysiological mechanismsTherapeutic optionsNeurocritical care researchTherapeutic targetNeurological patientsNew treatmentsFDA approvalNovel interventionsCare researchNew preventiveRehabilitation strategiesBiological pathwaysPatientsIllness
2015
Stroke is ascendant: is it time for TICI to be more than just a score?
Hirsch JA, Falcone GJ, Brook AL, Fiorella D, Gonzalez RG, Leslie-Mazwi TM. Stroke is ascendant: is it time for TICI to be more than just a score? Journal Of NeuroInterventional Surgery 2015, 8: 221. PMID: 26658463, DOI: 10.1136/neurintsurg-2015-012160.Peer-Reviewed Original Research